Home
Article
Archive
2000 2001
Editor:
Neil
Johnston
Columnists:
Rollo
Manning
Leigh
Kibby
Jon
Aldous
Roy
Stevenson
Brett
Clark
Ken
Stafford
Pat
Gallagher
Heather
Pym
Simon
Rudderham
Mark
Coleman
James
Ellerson
Terry
Irvine
Roundup
Peter
Sayers
NOVEMBER, Edition # 37, 2001
[Home] [About The Newsletter] [Topics Covered] [Testimonials]
SIMON RUDDERHAM
STUDENT ISSUES
Patient
Counselling -
Is there something you are missing?
Click on the Newsletter Reader's Forum link to access a forum from which you can express your comment or viewpoint on this article.
The author values your input, so please take the time to register your details, and participate in the only free debate on the future of Australian pharmacy.
Registration is free, and required once only, for permanent access.
You do not need to register if you only wish to view comments.
Imagine this.
A pharmacy that did not provide advice on the medications which they were selling.
A pharmacy that did not check for drug interactions.
A pharmacy that asked no questions before handing out the medications.
A pharmacy that is probably EXACTLY like yours.
A lot of work has (rightly) been undertaken by the PSA and the Pharmacy Guild to increase the amount of advice and counseling given to Schedule two and Schedule three medications, and yes, some of their reasons for doing so (e.g. retaining sole rights to sales) are probably not as noble as an increased concern over patient welfare.
There are, however, many pharmacists who can well say that they have the best Schedule two and Schedule three standard operating procedures.
But is your pharmacy like this?
(Taken from Natural Health Review Sept/Oct 2001, p.30)
There are many complementary therapies that can interact with allopathic medicines and decrease their effectiveness, or potentially cause severe harm. While (hopefully) everyone is aware of SSRIs and St John's Wort, there are many more drug-herbal interactions that require a brief note as to what medications the person is taking, and a CHECK through E-MIMS, Micromedex or HyperHealth to assess whether it is at the very least not going to harm the patient.
GROAN!I hear you all say. Here is this young upstart who is still a student, hasn't practised yet, and has not idea about how complex running a pharmacy is and how little time there is and (insert excuse here) etc.
All I ask is that if you choose to sell a substance, you should choose (read: have a duty) to know that it will not cause harm to the patient.Ends
 Previous Article |
 Next Article |
Back
to Article Index
Newsletter
Reader's Forum
|
||||
|
||||
|
*
Please contact us if you would like further information or would like us to research additional material to publish as future articles. |
*
Don't forget to advise of any change in your e-mail address so that your subscription may be continued without interruption. |
*
Letters to the editor are encouraged, or if you have material you would like published, please forward to the editor. |
*
Any interested persons who would like to receive this free newsletter on their desktop each fortnight, please send a single word e-mail "Subscribe" |
*
|
|
*
All Communications to:
neilj@computachem.com.au |
||||
|
*
You are invited to visit the Computachem web site and check out
an organised reference site for medical or other references.
Why not try (and bookmark) the Computachem Interweb Directory for an easily accessed range of medical and pharmacy links, plus a host of pharmacy relevant links. The directory also contains a very fast search engine for Internet enquiries. You may also access the Home Page at: http://www.computachem.com.au |
||||